| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.51▼ | 1.51▼ | 1.51▼ | 1.47▲ | 1.43▲ |
| MA10 | 1.50▼ | 1.50▼ | 1.50▼ | 1.43▲ | 1.60▼ |
| MA20 | 1.50▼ | 1.49▼ | 1.48▲ | 1.44▲ | 1.83▼ |
| MA50 | 1.46▲ | 1.44▲ | 1.43▲ | 1.63▼ | 1.92▼ |
| MA100 | 1.42▲ | 1.44▲ | 1.44▲ | 1.82▼ | 1.17▲ |
| MA200 | 1.43▲ | 1.54▼ | 1.62▼ | 1.97▼ | 1.39▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.002▼ | -0.001▼ | 0.023▲ | -0.067▼ |
| RSI | 50.459▲ | 52.430▲ | 53.915▲ | 47.468▼ | 44.594▼ |
| STOCH | 57.540 | 55.952 | 34.392 | 69.079 | 17.824▼ |
| WILL %R | -71.429 | -77.778▼ | -77.778▼ | -35.714 | -86.205▼ |
| CCI | -39.233 | -26.500 | -30.435 | 144.786▲ | -68.345 |
|
Friday, April 03, 2026 08:00 AM
The awards were approved by the Compensation Committee of the Company’s Board of Directors and were granted outside of the Company’s 2023 Equity Incentive Plan, with a grant date of April 1, 2026, as ...
|
|
Tuesday, February 24, 2026 12:00 AM
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and autoimmune ...
|
|
Monday, February 09, 2026 05:00 AM
NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (INAB) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell therapies and T cell engagers for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/04/26 | 1.51 | 1.54 | 1.49 | 1.49 | 50,773 |
| 21/04/26 | 1.56 | 1.59 | 1.4501 | 1.48 | 116,768 |
| 20/04/26 | 1.46 | 1.50 | 1.44 | 1.50 | 73,524 |
| 17/04/26 | 1.4603 | 1.465 | 1.42 | 1.44 | 18,586 |
| 16/04/26 | 1.42 | 1.48 | 1.3688 | 1.45 | 89,380 |
| 15/04/26 | 1.36 | 1.40 | 1.31 | 1.40 | 58,188 |
| 14/04/26 | 1.44 | 1.44 | 1.35 | 1.38 | 97,548 |
| 13/04/26 | 1.39 | 1.39 | 1.32 | 1.35 | 55,265 |
| 10/04/26 | 1.44 | 1.46 | 1.38 | 1.39 | 34,124 |
| 09/04/26 | 1.39 | 1.49 | 1.39 | 1.43 | 52,522 |
|
|
||||
|
|
||||
|
|